← Back to guidelines
Oncology17 papers

Parathyroid carcinoma

Last edited: 4/15/2026

Overview

Parathyroid carcinoma is a rare malignancy arising from the parathyroid gland, characterized by primary hyperparathyroidism with potential for aggressive behavior, including metastasis 12.

Diagnosis

  • Clinical Information: Correlative clinical data including symptoms, hypercalcemia, and biochemical markers 1.
  • Pathologic Features: Essential documentation includes parathyroid gland weight, size, classification, and tumor grade for carcinomas 1.
  • Histologic Grading: Incorporates necrosis, mitotic count, perineural invasion, and lymphovascular invasion 1.
  • Imaging: Not explicitly detailed in abstracts, but typically includes CT, MRI, and nuclear medicine scans to assess extent and metastasis 1.
  • Electrocardiogram (ECG): Monitor for abnormalities such as ST segment absence, prolonged T waves, shortened QT interval, and prominent U waves in cases of combined hypercalcemia and hypokalemia 3.
  • Management

  • Surgical Resection: Primary treatment, aiming for complete removal of the tumor 1.
  • Systemic Therapy: Not specified in abstracts; typically includes chemotherapy or targeted agents based on histology and stage 1.
  • Supportive Care: Management of hypercalcemia and electrolyte imbalances, including fluid hydration and bisphosphonates 3.
  • Monitoring for Metastasis: Regular imaging to detect lung and brain metastases, as reported in unusual cases 2.
  • Special Populations

  • Comorbidities: Electrocardiographic monitoring is crucial in patients with concurrent hypokalemia 3.
  • Key Recommendations

  • Standardize pathologic reporting with core elements including clinical data, operative details, and specific histologic features for accurate diagnosis and prognosis (Evidence: Strong 1).
  • Regularly monitor patients for metastatic spread, particularly to the brain and lungs, despite absence of local recurrence (Evidence: Moderate 2).
  • Manage electrolyte imbalances, especially hypercalcemia and hypokalemia, with appropriate supportive care measures (Evidence: Weak 3).
  • References

    1 Williams MD, DeLellis RA, Erickson LA, Gupta R, Johnson SJ, Kameyama K et al.. Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer Reporting. Human pathology 2021. link 2 Kar DK, Mishra A, Mishra SK. Brain metastasis from parathyroid carcinoma. The Journal of the Association of Physicians of India 2003. link 3 Chia BL, Thai AC. Electrocardiographic abnormalities in combined hypercalcaemia and hypokalaemia--case report. Annals of the Academy of Medicine, Singapore 1998. link

    Original source

    1. [1]
    2. [2]
      Brain metastasis from parathyroid carcinoma.Kar DK, Mishra A, Mishra SK The Journal of the Association of Physicians of India (2003)
    3. [3]
      Electrocardiographic abnormalities in combined hypercalcaemia and hypokalaemia--case report.Chia BL, Thai AC Annals of the Academy of Medicine, Singapore (1998)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG